Skip to main content
Equibles

CANADA PENSION PLAN INVESTMENT BOARD

Pension

Position in RNA — Atrium Therapeutics, Inc.

CIK 1283718 TORONTO ONTARIO, A6
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$564,496
+$3,358 QoQ
Shares Held
41,970
0.0% QoQ
Ownership
0.245%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CANADA PENSION PLAN INVESTMENT BOARD holds $1,122,840,645 across 119 Biotechnology names. RNA ranks #48 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 355,082 $176,379,881
2 KLRA
Kailera Therapeutics, Inc.
 7,304,688 $160,922,276
3 REGN
Regeneron Pharmaceuticals, Inc.
 209,911 $130,887,904
4 ALNY
Alnylam Pharmaceuticals, Inc.
 334,246 $100,618,073
5 ARGX
Argenx SE
 60,577 $56,201,523
6 AXSM
Axsome Therapeutics, Inc.
 225,400 $55,171,158
7 INCY
Incyte Corp
 442,500 $50,161,800
8 SPTX
Seaport Therapeutics, Inc.
 1,975,791 $42,914,180

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $564,496 41,970
2026-03-31 $561,138 41,970